Family support program to help teens with depression or anxiety who are in substance use treatment
Official title: Testing the Feasibility of a Family-based Adjunctive Treatment Protocol for Targeting Co-Occurring Internalizing Disorders Among Adolescents With SUD
Run by The National Center on Addiction and Substance Abuse at Columbia University · NCT06413979 · Data updated 2026-11-12
This project will test whether adding a brief family support program (Fam-AID) to usual outpatient substance use care helps adolescents (ages 13–21) with depression or anxiety symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 20 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | The National Center on Addiction and Substance Abuse at Columbia University Academic / other |
| Locations | 3 sites (Chicago, Illinois and 2 other locations) |
| Status | Recruiting |
| Started | July 29, 2025 |
| Main results expected | January 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT06413979 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 13–21 who are active outpatients for substance use, live with a primary caregiver who can attend sessions, and have current symptoms or diagnoses of depressive or anxiety disorders.
✕Probably not a fit
Teens who require inpatient hospitalization, detox or residential placement, have current psychosis, or have pervasive developmental disorders, or those without a caregiver able to participate, are unlikely to benefit from this outpatient adjunct.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This R34 project develops and pilots an adjunctive family-support protocol called Fam-AID to address co-occurring internalizing disorders in adolescents receiving community outpatient care for substance use. Fam-AID is delivered with a primary caregiver alongside usual care and is designed to be briefer and easier to scale than intensive manualized integrated models. The protocol will be tested across three U.S. clinical sites for feasibility, acceptability, and preliminary clinical effects on internalizing symptoms and substance use engagement. Eligible participants are youth aged 13–21 enrolled in outpatient substance use treatment who have current depressive or anxiety symptoms or diagnoses, while those with severe acute needs (e.g., detox, inpatient) are excluded.
Why it matters
Potential benefit: If successful, Fam-AID could reduce depressive and anxiety symptoms in adolescents and improve engagement and outcomes in outpatient substance use treatment.
How similar studies have gone: Previous integrated behavioral models for co-occurring adolescent substance use and internalizing disorders have shown some promise but tend to be intensive and difficult to scale, making this brief, family-focused adjunct relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Youth is age 12-20. * Youth lives with a primary caregiver who can attend treatment sessions. * Youth endorses one or more DSM-5-TR symptoms for SUD and meets American Society of Addiction Medicine criteria for outpatient SU treatment. * Youth meets DSM-5-TR criteria, or has elevated symptoms and impairment, for any of the following IDs: Current or Recurrent Major Depressive Episode, Pervasive Depressive Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder, Panic Disorder, Posttraumatic Stress Disorder. * Youth completes intake and is enrolled as an active case at study site Exclusion Criteria: * Illness requiring hospitalization * Current psychotic symptoms * Severe SU problems that require immediate relief (detox or residential placement) * Pervasive developmental disorder.
Where it's running
-
Lurie Children's Hospital
Chicago, Illinois, United States Recruiting -
Indiana University School of Medicine
Indianapolis, Indiana, United States Recruiting -
Roberto Clemente Center
New York, New York, United States Recruiting
Study contacts
- Study coordinator: Nicole P Porter, PhD
- Email: nporter@toendaddiction.org
- Phone: (212) 841-5211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Interdisciplinary support to smooth care transitions for hospitalized adults with substance use disorders
This study tests a team-based in-hospital and post-discharge program to help adults with substance use disorders move from hospital care to ongoing community treatment.
-
Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice (MISSION-CJ) for re-entry
This trial tests a multicomponent program called MISSION-CJ with Peer Linkage Support to help adults released from two Massachusetts jails who have both mental health and substance use disorders.
-
Helping toddlers of caregivers with substance use disorders build language skills with group and individualized parenting supports
This project will test whether adding coaching and one-on-one lessons to a group parenting program helps toddlers (12–42 months) of caregivers with substance use disorders develop better language skills.
-
Recovery Inspired Support Engagement: A 12‑week 1-on-1 program for families and friends supporting someone in recovery
A 12‑week telehealth program will test whether a one‑on‑one support program for people who support loved ones in substance use recovery is doable and acceptable.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.